Pharmacologic Treatment of Alcohol Withdrawal

JAMA: The Journal of the American Medical Association

Volumn 278, Issue 16, 1997, Pages 1317-

  Johnson, James R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; GLUCOSE; THIAMINE; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; PLACEBO; ANXIOLYTIC AGENT;

HUMAN; NOTE; WERNICKE ENCEPHALOPATHY; WITHDRAWAL SYNDROME; AMBULATORY CARE; HOSPITALIZATION; ALCOHOL WITHDRAWAL; CLINICAL TRIAL; DELIRIUM TREMENS; LETTER; META ANALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ETHANOL; GLUCOSE; HUMANS; SUBSTANCE WITHDRAWAL SYNDROME; THIAMINE; WERNICKE ENCEPHALOPATHY; AMBULATORY CARE; HOSPITALIZATION; ALCOHOL WITHDRAWAL DELIRIUM; ANTI-ANXIETY AGENTS; BENZODIAZEPINES;

EID: 0030823157     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03550160037025     Document Type: Letter

References (1)

1. Mayo-Smith MF, for the American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA. 1997;278:144-151.